Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 826 clinical trials
Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer

Sentinel lymph node (SLN) biopsy is the gold standard method to stage axilla in breast cancer. The aim of the study is to compare the efficiency of various methods to identify SLN is breast cancer patients.

sentinel lymph node biopsy
sentinel node
excisional biopsy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer

Prospective randomized study comparing 5 fractions in alternative days to standard 15 fractions regarding effectiveness and feasibility during adjuvant treatment in breast caner patients aged above 50 years

invasive breast cancer
adjuvant radiotherapy
stage iv breast cancer
hypofractionated radiation therapy
ct scan chest
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

Several studies are investigating the anti-tumor effect of metformin in early breast cancer. However, the enhancing effect of metformin on anti-tumor immunity has only been demonstrated in animal models. This study examines the immune effect of metformin in breast cancer patients treated with preoperative chemotherapy.

metastasis
breast carcinoma
carcinoma
metformin
preoperative chemotherapy
  • 0 views
  • 19 Feb, 2024
  • 1 location
Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

This is an open label, single arm, multicenter, phase Ib study to evaluate the safety and clinical activity of the combination of ipatasertib, trastuzumab and pertuzumab in patients with unresectable locally advanced or metastatic HER2-positive breast cancer with tumors harboring PIK3CA mutations, candidates to receive maintenance HP after first line …

serum bilirubin
ejection fraction
invasive breast cancer
stage iv breast cancer
ipatasertib
  • 0 views
  • 19 Feb, 2024
  • 10 locations
Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer

This single arm pilot study evaluates the use of neoadjuvant endocrine therapy in women with early stage ER+ breast cancer who are 70 years or older and are scheduled to have breast conservation surgery (BCS). The purpose of this study is to see if tolerance of neoadjuvant endocrine therapy helps …

anastrozole
tamoxifen
invasive breast cancer
estrogen receptor positive breast cancer
HER2
  • 0 views
  • 19 Feb, 2024
  • 1 location
Optimizing Quality of Life in Women Living With Metastatic Breast Cancer

The purpose of this study is to develop and tailor an intervention program to improve the quality of life in women living with metastatic breast cancer. In the first phase of this study, we conducted patient focus groups to gather information about the unique challenges of living with MBC and …

female breast cancer
stage iv breast cancer
acceptance and commitment therapy
breast cancer
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

This study is a one-arm, open, phase II clinical study, and the study subjects are locally advanced and inflammatoryPatients with sexual or early HER2-positive breast cancer entered the trial period after signing informed consentTo evaluate trastuzumab combined with pyrrolitinib and chemotherapy regimen (TCbH+Py) for HER2 positive breastPathologic complete response rate …

primary lesion
bisphosphonate therapy
ejection fraction
invasive breast cancer
her2+ breast cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pyrotinib Trastuzumab Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

This study aims to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab, pertuzumab and nab-paclitaxel as neoadjuvant therapy in early stage or locally advanced HER2-positive breast cancer.

paclitaxel
carcinoma
primary tumor
invasive breast cancer
estrogen
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT)

This is a randomized clinical trial (OMIT study) evaluating the efficacy of metastasectomy in patients with oligo-metastatic breast cancer.

blood transfusion
stage iv breast cancer
measurable disease
kidney function tests
metastasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.

The objective of this study is to demonstrate the feasibility of using the Flexitouch Plus with Cellular Connectivity (FT-CC) to monitor device use data to determine if reminders to patients impact compliance, and to identify the impact device compliance has on arm girth, quality of life (QOL), and symptom assessment.

  • 0 views
  • 19 Feb, 2024
  • 2 locations